CD8A and acute myeloid leukemia: Peptide-HLA prediction algorithms demonstrated upregulation of potential HLA-I epitopes in response to DNMTi and HDACi [96]; and CD8 T cell populations in acute myeloid leukemia (AML) patients recognized ERV-derived peptides both pre- and post DNMTi treatment [97].